Empirical Asset Management »

Akebia Therapeutics shares owned by Empirical Asset Management

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Empirical Asset Management from 13F filings

Historical chart of Empirical Asset Management investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by Empirical Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by Empirical Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $55k 20k 2.73
2025-03-31 $19k 10k 1.92
2024-12-31 $25k 13k 1.90
2024-09-30 $45k 34k 1.32

More positions owned by Empirical Asset Management

Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr U.s. Tech Etf (IYW)
Etfs Gold Tr Physcl Gold Shs (SGOL)
Meta Platforms Cl A (META)
Home Depot (HD)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Uscf Etf Tr Summerhaven K1 (SDCI)
Spdr Gold Tr Gold Shs (GLD)
Ishares Silver Tr Ishares (SLV)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exchange Traded Fd T S&p500 Eql Tec (RSPT)

View all positions for Empirical Asset Management

Top funds holding Akebia Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Morgan Stanley
Renaissance Technologies
UBS Group
Citadel Advisors
Qube Research & Technologies
MPM Oncology Impact Management
Millennium Management
Franklin Resources
Northern Trust
Affinity Asset Advisors
Invesco

View all funds holding Akebia Therapeutics